Consolidated Statements Of Operations (USD $)	3 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
Net revenues:
Product revenue	$ 2,269,577	$ 2,406,580
Revenues, net	2,269,577	2,406,580
Costs and expenses:
Cost of goods sold	1,196,398	1,224,428
Marketing, general and administrative	1,405,586	1,381,882
Research and development	264,198	219,551
Total costs and expenses	2,866,182	2,825,861
Loss from operations	(596,605)	(419,281)
Other (expense) income:
Gain (Loss) Related to Litigation Settlement	63,589	0
Equity in Ocular Telehealth Management, LLC	1,192	699
Interest income	24	43
Interest expense	(92,596)	(82,491)
Total other (expense) income	(27,791)	(81,749)
Net loss from continuing operations before taxes	(624,396)	(501,030)
Benefit of income taxes	0	0
Net (loss) from continuing operations	(624,396)	(501,030)
Income(loss) from discontinued operations	190,960	(288,619)
Net loss	$ (433,436)	$ (789,649)
Basic:
Income (Loss) from Continuing Operations, Per Basic Share	$ (0.08)	$ (0.06)
Income (Loss) from Discontinued Operations, Net of Tax, Per Basic Share	$ 0.02	$ (0.04)
Net income (loss)	$ (0.06)	$ (0.10)
Diluted:
Income (Loss) from Continuing Operations, Per Diluted Share	$ (0.08)	$ (0.06)
Discontinued operations	$ 0.02	$ (0.04)
Net income (loss)	$ (0.06)	$ (0.10)
Weighted Average Number of Shares Outstanding, Basic	7,526,430	7,526,430
Weighted Average Number of Shares Outstanding, Diluted	7,526,430	7,526,430